Clinical trial

In Vivo Alzheimer Proteomics

NCT02263235

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2013-10-08

PhaseNA

Study timeline

Study start (actual)2013-10-08Date precision: day

Registry last updated2021-12-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Probable Alzheimer Diseaseunresolved

Parkinson Diseaseunresolved

Neurological Disease Without Cognitive Degradationunresolved

Brain Traumaunresolved

Acute Hydrocephalyunresolved

Interventions

administration of stable isotope-labelled leucine-BIOLOGICAL

collection of CSF, blood, urine, salivaOTHER

Sponsors & collaborators

University Hospital, Montpellierlead sponsor

Assistance Publique - Hôpitaux de Pariscollaborator

University Hospital, Clermont-Ferrandcollaborator

International Atomic Energy Agencycollaborator

Mapped research locations

MontpellierFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02263235 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.